This year, your flu shot will be given via “microneedle,” a new technology that will eliminate pain.
The new vaccine technology was FDA-approved last year and eliminates pain and sore arm.
Sanofi Pasteur and Actor Chris O’Donnell Launch Fluzone® Intradermal (Influenza Virus Vaccine) VacciNation Tour to Raise Awareness About Importance of Annual Flu Shot and Vaccine Options for Adults.
“I understand the importance of helping to protect myself against the flu, which is why I got my flu vaccination,” said O’Donnell. “When my doctor and I talked this year about what may make my experience a good one, we determined Fluzone Intradermal vaccine was the best choice for me. The device has a needle smaller than a grain of rice, which for me, made a big difference.”
Fluzone is the latest of two technologies approved for use for the influenza vaccine.
The technology is manufactured by Sanofi Pasteur Inc., and works by forcing the vaccine through the skin via “microneedles”.
This vaccine offers fewer side effects than a standard vaccine.
Fluzone is approved for use in adults and is available nationwide.
This week, the American Academy of Pediatrics updated its guidelines to urge all children over 6 months to get vaccinated.
The U.S. Centers for Disease Control and Prevention recommends that all healthy adults get vaccinated as soon as the vaccine is available in your community.
On average, influenza and its related complications result in approximately 226,000 hospitalizations.
You can also talk to your health care provider or pharmacist for more information.